161 related articles for article (PubMed ID: 31368851)
1. A case for genotype-guided pain management.
Cavallari LH; Johnson JA
Pharmacogenomics; 2019 Jul; 20(10):705-708. PubMed ID: 31368851
[No Abstract] [Full Text] [Related]
2. CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial.
Smith DM; Weitzel KW; Elsey AR; Langaee T; Gong Y; Wake DT; Duong BQ; Hagen M; Harle CA; Mercado E; Nagoshi Y; Newsom K; Wright A; Rosenberg EI; Starostik P; Clare-Salzler MJ; Schmidt SO; Fillingim RB; Johnson JA; Cavallari LH
Genet Med; 2019 Aug; 21(8):1842-1850. PubMed ID: 30670877
[TBL] [Abstract][Full Text] [Related]
3. Design and rational for the precision medicine guided treatment for cancer pain pragmatic clinical trial.
Mosley SA; Hicks JK; Portman DG; Donovan KA; Gopalan P; Schmit J; Starr J; Silver N; Gong Y; Langaee T; Clare-Salzler M; Starostik P; Chang YD; Rajasekhara S; Smith JE; Soares HP; George TJ; McLeod HL; Cavallari LH
Contemp Clin Trials; 2018 May; 68():7-13. PubMed ID: 29535047
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics and prescription opioid use.
Benjeddou M; Peiró AM
Pharmacogenomics; 2021 Mar; 22(4):235-245. PubMed ID: 33445954
[TBL] [Abstract][Full Text] [Related]
5. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
Ruano G; Kost JA
Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of pharmacogenetics in pain management.
Smith DM; Weitzel KW; Cavallari LH; Elsey AR; Schmidt SO
Per Med; 2018 Mar; 15(2):117-126. PubMed ID: 29714124
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and Utility of the Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.
Ruan X; Bumgarner GW; Labrie-Brown C; Kaye AD
Clin J Pain; 2016 Dec; 32(12):1105-1106. PubMed ID: 26889610
[No Abstract] [Full Text] [Related]
8. Clinical perspective on the Clinical Pharmacogenetics Implementation Consortium Updated 2014 guidelines for CYP2D6 and codeine.
Nicholson WT; Formea CM
Clin Chem; 2015 Feb; 61(2):319-21. PubMed ID: 25301855
[No Abstract] [Full Text] [Related]
9. Evidence Regarding Pharmacogenetics in Pain Management and Cancer.
Smith DM; Figg WD
Oncologist; 2023 Mar; 28(3):189-192. PubMed ID: 36718020
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of pain management in Zimbabwean patients with sickle cell disease.
Mapira NL; Thelingwani RS; Chikwambi Z; Kuona P; Masimirembwa C
Pharmacogenomics; 2023 May; 24(7):359-369. PubMed ID: 37248824
[No Abstract] [Full Text] [Related]
11. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
Owusu Obeng A; Hamadeh I; Smith M
Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
[TBL] [Abstract][Full Text] [Related]
12. The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy.
Reynolds KK; Ramey-Hartung B; Jortani SA
Clin Lab Med; 2008 Dec; 28(4):581-98. PubMed ID: 19059064
[TBL] [Abstract][Full Text] [Related]
13. Use of pharmacogenetic data to guide individualized opioid prescribing after surgery.
Rocco R; Thiels CA; Ubl DS; Moyer AM; Habermann EB; Cassivi SD
Surgery; 2019 Oct; 166(4):476-482. PubMed ID: 31320226
[TBL] [Abstract][Full Text] [Related]
14. Suspected opioid overdose case resolved by CYP2D6 genotyping.
Shaw KD; Amstutz U; Jimenez-Mendez R; Ross CJ; Carleton BC
Ther Drug Monit; 2012 Apr; 34(2):121-3. PubMed ID: 22406651
[TBL] [Abstract][Full Text] [Related]
15. OCT1 pharmacogenetics in pain management: is a clinical application within reach?
Tzvetkov MV
Pharmacogenomics; 2017 Nov; 18(16):1515-1523. PubMed ID: 29061087
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics in pain management: the clinical need.
Webster LR
Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063
[TBL] [Abstract][Full Text] [Related]
17. Opioid genetics: the key to personalized pain control?
Branford R; Droney J; Ross JR
Clin Genet; 2012 Oct; 82(4):301-10. PubMed ID: 22780883
[TBL] [Abstract][Full Text] [Related]
18. CYP2D6-guided opioid therapy for adults with cancer pain: A randomized implementation clinical trial.
Mosley SA; Cicali E; Del Cueto A; Portman DG; Donovan KA; Gong Y; Langaee T; Gopalan P; Schmit J; Starr JS; Silver N; Chang YD; Rajasekhara S; Smith JE; Soares HP; Clare-Salzler M; Starostik P; George TJ; McLeod HL; Fillingim RB; Hicks JK; Cavallari LH
Pharmacotherapy; 2023 Dec; 43(12):1286-1296. PubMed ID: 37698371
[TBL] [Abstract][Full Text] [Related]
19. Codeine and opioid metabolism: implications and alternatives for pediatric pain management.
Chidambaran V; Sadhasivam S; Mahmoud M
Curr Opin Anaesthesiol; 2017 Jun; 30(3):349-356. PubMed ID: 28323671
[TBL] [Abstract][Full Text] [Related]
20. Pain polymorphisms and opioids: An evidence based review.
Vieira CMP; Fragoso RM; Pereira D; Medeiros R
Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
